Michelle Pratt
Family · Long Beach, CANPI 1174541171
Payments from drug & device makers
Across 497 payments — averaging $26.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Biogen$2K
- Amgen$2K
- UCB SA$1K
- Johnson & Johnson$982
- GSK$757
- plus $5K from 23 others
What the payments were for
- Travel & lodging$2,07215%
- Food & beverage$11,12783%
- Education$1871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 127 | $2,090 |
| Biogen | 13 | $1,775 |
| Amgen(2 entities) | 69 | $1,521 |
| UCB SA | 8 | $1,137 |
| Johnson & Johnson | 41 | $982 |
| GSK | 33 | $757 |
| Aurinia Pharma U.S., Inc. | 22 | $676 |
| Pfizer | 33 | $673 |
| Lilly USA, LLC | 28 | $635 |
| AstraZeneca(2 entities) | 24 | $544 |
| Novartis | 21 | $499 |
| UCB, Inc. | 11 | $393 |
| Radius Health, Inc. | 14 | $360 |
| Organon | 17 | $356 |
| Fresenius Kabi USA, LLC | 9 | $262 |
| Boehringer Ingelheim | 6 | $171 |
| Actelion Pharmaceuticals US, Inc. | 2 | $130 |
| ANI Pharmaceuticals, Inc. | 3 | $82 |
| Mallinckrodt Hospital Products Inc. | 2 | $62 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Cumberland Pharmaceuticals, Inc. | 3 | $46 |
| Sanofi | 1 | $33 |
| Sandoz | 1 | $30 |
| Alvogen Inc | 2 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Eisai Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Merck | 1 | $16 |
How this compares
$13,386 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 26 | $243,199 |
| Enbrel SureclickEtanercept | 22 | $201,260 |
| Xeljanz XrTofacitinib Citrate | 19 | $102,132 |
| TymlosAbaloparatide | 30 | $78,668 |
| ProliaDenosumab | 45 | $74,443 |
| OrenciaAbatacept/Maltose | 12 | $36,477 |
| TrulicityDulaglutide | 20 | $19,136 |
| JanuviaSitagliptin Phosphate | 13 | $6,898 |
| MethotrexateMethotrexate Sodium | 67 | $2,369 |
| Diclofenac Sodium | 12 | $1,910 |
| Duloxetine Hcl | 44 | $1,908 |
| Hydroxychloroquine Sulfate | 43 | $1,786 |
| Gabapentin | 45 | $754 |
| Naproxen | 12 | $429 |
| Leflunomide | 12 | $370 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Radius Health, Inc.Tymlos | $360 | $78,66830 claims |
| AmgenProlia | $1,521 | $74,44345 claims |
| Lilly USA, LLCTrulicity | $635 | $19,13620 claims |
| MerckJanuvia | $16 | $6,89813 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $82 | $29111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Long Beach
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.